We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Diagnostics Presents Latest Diabetes Care Analyzers

By LabMedica International staff writers
Posted on 31 Jan 2019
EKF Diagnostics (Cardiff, Wales, UK) presented its latest diabetes care analyzers at MedLab Middle East, a leading laboratory and flagship exhibition and conference spanning across the Middle East, Asia and West Europe. More...
MedLab Middle East 2019 provided an international platform for laboratory management and medicine to exhibit their products ranging from ayurvedic & herbal to medical & pharmaceutical essentials in medical research & development & scientific instruments. The Conference provided education, best practices and the chance to learn, meet and network with leading laboratorians from across the globe.

At MedLab Middle East, EKF Diagnostics displayed DiaSpect Tm, the world’s fastest hemoglobin analyzer that delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The hemoglobin analyzer is palm-sized, making it easily transportable, and ideal for use in any screening setting even in challenging climatic environments. EKF Diagnostics also exhibited the Quo-Lab HbA1c desktop point-of-care analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use.

Also on display at the event was EKF Diagnostics’ Quo-Test HbA1c system, a fully automated HbA1c analyzer that uses patented boronate affinity fluorescence quenching technology to measure HbA1c from a 4-μl sample taken from a finger prick or venous whole blood. It has been designed for easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting such as diabetes clinics and doctors’ surgeries. EKF Diagnostics’ also exhibited Hemo Control, its point-of-care hemoglobin analyzer designed to provide quantitative, lab quality hemoglobin results from 25 seconds. Hemo Control uses the most established photometric azide methemoglobin method, ensuring reliable results with a high precision (CV <2%).

Among the latest products displayed by EKF Diagnostics at MedLab Middle East was its new Lactate Scout 4 lactate analyzer for athletes. Lactate Scout 4 is used by sports medicine and sport professionals for the easy and reliable measurement of lactate while training on the track, working out in the gym or analyzing their performance in the laboratory. It has been ergonomically designed to be effectively used in the field as a training companion for coaches and athletes to determine optimum training programs, define training zones, and avoid inefficient training exercises. The hand-held lactate analyzer requires just 0.2 µl of capillary blood and returns results in 10 seconds. Up to 500 results can be stored on the Lactate Scout 4, which also features easy connection to heart rate monitors, stopwatch function to aid performance measurement, integrated step test function and Bluetooth connectivity.


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Creatine Kinase-MB Assay
CK-MB Test
New
Slide Scanner
VENTANA DP 600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.